Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Merck’s melanoma drug shows early promise for resistant cancers in PhI trial
Merck’s melanoma drug shows early promise for resistant cancers in PhI trial
Merck’s melanoma drug shows early promise for resistant cancers in PhI trial
Submitted by
admin
on February 24, 2018 - 10:21am
Source:
Endpoints
News Tags:
Merck
melanoma
clinical trials
MK-8353
Headline:
Merck’s melanoma drug shows early promise for resistant cancers in PhI trial
Do Not Allow Advertisers to Use My Personal information
